What does a device called the Fluoroscope that measured feet have in common with modern-day DNA medicines? History has a way of repeating

The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

I recently sat down with Brad Younggren, MD, Chief Medical Officer of 98point6, the growing medical technology platform providing text-first, primary care consults with...

A bioactive polymer-ceramic composite for fixing implants and restoring bone defects in the skull was developed by an international group of materials scientists